329 related articles for article (PubMed ID: 27498604)
1. Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation.
Bonecchi R; Garlanda C; Mantovani A; Riva F
Cytokine; 2016 Nov; 87():37-45. PubMed ID: 27498604
[TBL] [Abstract][Full Text] [Related]
2. Tuning of innate immunity and polarized responses by decoy receptors.
Mantovani A; Bonecchi R; Martinez FO; Galliera E; Perrier P; Allavena P; Locati M
Int Arch Allergy Immunol; 2003 Oct; 132(2):109-15. PubMed ID: 14600422
[TBL] [Abstract][Full Text] [Related]
3. Regulatory pathways in inflammation.
Mantovani A; Garlanda C; Locati M; Rodriguez TV; Feo SG; Savino B; Vecchi A
Autoimmun Rev; 2007 Nov; 7(1):8-11. PubMed ID: 17967718
[TBL] [Abstract][Full Text] [Related]
4. Negative Regulation of the IL-1 System by IL-1R2 and IL-1R8: Relevance in Pathophysiology and Disease.
Supino D; Minute L; Mariancini A; Riva F; Magrini E; Garlanda C
Front Immunol; 2022; 13():804641. PubMed ID: 35211118
[TBL] [Abstract][Full Text] [Related]
5. Negative regulatory receptors of the IL-1 family.
Garlanda C; Riva F; Bonavita E; Mantovani A
Semin Immunol; 2013 Dec; 25(6):408-15. PubMed ID: 24239046
[TBL] [Abstract][Full Text] [Related]
6. Wandering pathways in the regulation of innate immunity and inflammation.
Mantovani A
J Autoimmun; 2017 Dec; 85():1-5. PubMed ID: 29079064
[TBL] [Abstract][Full Text] [Related]
7. Tuning inflammation and immunity by chemokine sequestration: decoys and more.
Mantovani A; Bonecchi R; Locati M
Nat Rev Immunol; 2006 Dec; 6(12):907-18. PubMed ID: 17124512
[TBL] [Abstract][Full Text] [Related]
8. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines.
Mantovani A; Locati M; Vecchi A; Sozzani S; Allavena P
Trends Immunol; 2001 Jun; 22(6):328-36. PubMed ID: 11377293
[TBL] [Abstract][Full Text] [Related]
9. Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR.
Mantovani A; Locati M; Polentarutti N; Vecchi A; Garlanda C
J Leukoc Biol; 2004 May; 75(5):738-42. PubMed ID: 14673019
[TBL] [Abstract][Full Text] [Related]
10. Novel pathways for negative regulation of inflammatory cytokines centered on receptor expression.
Mantovani A; Garlanda C
Dev Biol Stand; 1999; 97():97-104. PubMed ID: 10463535
[No Abstract] [Full Text] [Related]
11. Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8.
Molgora M; Supino D; Mantovani A; Garlanda C
Immunol Rev; 2018 Jan; 281(1):233-247. PubMed ID: 29247989
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic expression of the atypical chemokine receptor ACKR2 is involved in the systemic regulation of glucose tolerance.
Fioravante M; Bombassaro B; Ramalho AF; de Moura RF; Haddad-Tovolli R; Solon C; Dragano NR; Vettorazzi JF; Gaspar RS; Ropelle ER; Carneiro EM; Morari J; Velloso LA
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1126-1137. PubMed ID: 30738810
[TBL] [Abstract][Full Text] [Related]
13. Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8.
Li S; Neff CP; Barber K; Hong J; Luo Y; Azam T; Palmer BE; Fujita M; Garlanda C; Mantovani A; Kim S; Dinarello CA
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2497-502. PubMed ID: 25654981
[TBL] [Abstract][Full Text] [Related]
14. The family of the interleukin-1 receptors.
Boraschi D; Italiani P; Weil S; Martin MU
Immunol Rev; 2018 Jan; 281(1):197-232. PubMed ID: 29248002
[TBL] [Abstract][Full Text] [Related]
15. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress.
O'Neill LA
Immunol Rev; 2008 Dec; 226():10-8. PubMed ID: 19161412
[TBL] [Abstract][Full Text] [Related]
16. Role of atypical chemokine receptor ACKR2 in experimental oral squamous cell carcinogenesis.
da Silva JM; Dos Santos TPM; Saraiva AM; Fernandes de Oliveira AL; Garlet GP; Batista AC; de Mesquita RA; Russo RC; da Silva TA
Cytokine; 2019 Jun; 118():160-167. PubMed ID: 29550065
[TBL] [Abstract][Full Text] [Related]
17. The interleukin-1 receptor family.
Boraschi D; Tagliabue A
Semin Immunol; 2013 Dec; 25(6):394-407. PubMed ID: 24246227
[TBL] [Abstract][Full Text] [Related]
18. The interleukin-1 family: back to the future.
Garlanda C; Dinarello CA; Mantovani A
Immunity; 2013 Dec; 39(6):1003-18. PubMed ID: 24332029
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Atypical Chemokine Receptor Expression in T Cell Subsets.
Pacheco MO; Rocha FA; Aloia TPA; Marti LC
Cells; 2022 Dec; 11(24):. PubMed ID: 36552863
[TBL] [Abstract][Full Text] [Related]
20. Atypical chemokine receptor ACKR2 mediates chemokine scavenging by primary human trophoblasts and can regulate fetal growth, placental structure, and neonatal mortality in mice.
Teoh PJ; Menzies FM; Hansell CA; Clarke M; Waddell C; Burton GJ; Nelson SM; Nibbs RJ
J Immunol; 2014 Nov; 193(10):5218-28. PubMed ID: 25297873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
